Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	The Journal of Infection in Developing Countries 2024-05-01
Serie:	Journal of Infection in Developing Countries
Soggetti:	Chronic HCV infection hepatocellular carcinoma liver cirrhosis direct-acting antiviral agents
Accesso online:	https://jidc.org/index.php/journal/article/view/18410
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!